|
Variables
|
Multivariate (Model 1)
|
Multivariate (Model 2)
|
Multivariate (Model 3)
|
|---|
|
OR
|
95% CI
|
p-value
|
OR
|
95% CI
|
p-value
|
OR
|
95% CI
|
p-value
|
|---|
|
Patients with DM
|
|
Hypertension
|
0.435
|
0.157–1.145
|
0.092
| |
–
| |
0.438
|
0.105–6.510
|
0.105
|
|
Cre on admission, per 1 mg/dl
|
1.141
|
0.407–4.202
|
0.829
| |
–
| |
1.208
|
0.401–4.762
|
0.768
|
|
BNP during stable phase, per 1 pg/ml
|
1.002
|
0.999–1.005
|
0.053
| |
–
| |
1.002
|
0.999–1.005
|
0.072
|
|
HDLC, per 1 mg/dl
|
0.962
|
0.909–1.011
|
0.134
| |
–
| |
0.966
|
0.912–1.017
|
1.035
|
|
Glucose on admission > 180 mg/dl
| |
–
| |
2.415
|
0.861–7.232
|
0.094
|
2.038
|
0.660–6.666
|
0.217
|
|
HbA1c, per 1%
| |
–
| |
1.154
|
0.842–1.575
|
0.364
|
1.091
|
0.753–1.562
|
0.637
|
|
High MAGE
| |
–
| |
2.780
|
1.017–8.956
|
0.046
|
3.238
|
1.041–12.38
|
0.042
|
|
Patients with IGT
|
|
Multivessel disease
|
4.586
|
2.028–10.843
|
< 0.001
| |
–
| |
4.036
|
1.747–9.694
|
0.001
|
|
hs-CRP during stable phase > 0.1355 mg/dl
|
3.766
|
1.641–9.226
|
0.002
| |
–
| |
3.857
|
1.664–9.576
|
0.001
|
|
High MAGE
| |
–
| |
2.528
|
1.145–5.581
|
0.024
|
2.080
|
0.861–4.957
|
0.102
|
- Patients with DM: Model 1 hypertension, Cre on admission, BNP during stable phase and HDLC, Model 2 glucose on admission > 180 mg/dl, HbA1c high MAGE, Model 3 all variables included in Model 1 and 2; Patients with IGT: Model 1 multivessel disease and hs-CRP during stable phase > 0.1355 mg/dl, Model 2 included only High MAGE, Model 3 all variables included in Model 1 and 2. Other abbreviations as in Tables 1, 2, 3, 4
